Stay Informed on Corporate Sustainability

Author: Irish Sun

India-based Novo Nordisk has partnered with Emcure Pharma to launch Poviztra, a semaglutide injection for weight management. The collaboration expands distribution across India, strengthening access to innovative pharmaceutical treatments for obesity.

Author: PM LiVE

Smurfit Westrock has launched a €40 million clinical and adherence packaging facility at Dublin Airport. The site will support clinical trials and regulated pharmaceutical packaging for European markets, backed by a 170-strong specialised workforce.

Author: Investing.com

Geode Capital Management discloses a 2.24% stake in Ireland-based Avadel Pharmaceuticals, a company specialising in central nervous system drugs. The regulatory filing highlights increased institutional investment in the Irish pharma sector.

Author: pharmaphorum

Ireland-based specialty pharma company Keenova emerges from Mallinckrodt-Endo restructuring with a focus on branded medicines and a workforce of 1,600. The spinout sets the stage for a planned NYSE listing in 2026 and continued pipeline expansion.

Author: Jed Nykolle Harme

The pharma and life sciences sector continues to advance through operational performance, scientific innovation, and recognition of industry expertise. Organisations are navigating complex markets while driving breakthroughs that impact patients, research, and global healthcare. Strong performance demonstrates resilience and strategic focus. Teva’s Irish arm posts rising profits despite lower revenues highlights the ability of companies to optimise operations, maintain profitability, and invest in ongoing growth even amid challenging market conditions. Scientific innovation is shaping the sector’s trajectory. How SGS is advancing scientific excellence showcases the vital role of rigorous testing, analytical capabilities, and adaptive research strategies in supporting the biopharma landscape and meeting evolving industry standards. Meanwhile, Nuala Calnan to bring expertise to judging panel for the Pharma Industry Awards 2025, highlighting best-in-class practices and bringing more than 2 decades of leadership and expertise in the medtech and biopharmaceutical sectors. These developments reflect a sector where performance, scientific advancement, and leadership converge to drive innovation, operational excellence, and sustainable impact. Explore the full stories and stay informed on the breakthroughs shaping modern pharma and life sciences.

Author: Jed Nykolle Harme

Dr. Nuala Calnan, CEO of Biopharm Excel and Founder of The Quality Risk Management Institute, has been announced as a judge for the Pharma Industry Awards 2025, bringing over 25 years of leadership and expertise in the biopharmaceutical and medtech sectors.

Author: Jed Nykolle Harme

The global biopharmaceutical industry is evolving rapidly, driven by advances in biologics, cell and gene therapies, and an increasing demand for scientific insight alongside analytical support.

Author: RTE

Smurfit Westrock has launched a €40m clinical and adherence packaging facility near Dublin Airport, employing 170 staff, providing regulated pharma and clinical trial packaging, and reinforcing Ireland’s position in global healthcare innovation.

Author: FreightWaves

Cencora is investing $1 billion through 2030 to expand U.S. pharmaceutical distribution, adding advanced automation and cold chain capabilities in Ohio, California, and Alabama to ensure timely, reliable delivery of specialty and prescription medications.

Author: Contract Pharma

Pfizer to acquire Metsera for $10 billion, securing entry into the weight-loss drug market with Metsera’s GLP-1 and amylin-mimicking candidates, following Novo Nordisk withdrawal and antitrust concerns.